 REHOVOT, Israel and WILMINGTON, Del., June 02, 2022 GLOBE NEWSWIRE -- Ayala Pharmaceuticals, Inc. Nasdaq: AYLA, a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that it will participate in a Fireside Chat presentation at the Jefferies Healthcare Conference, to take place June 8-10, 2022, in New York, NY. The company will also be available for one-on-one meetings with institutional investors at the conference. 